Pharmacy evidence record · researched 2026-08-20

Strive Pharmacy

Strive Pharmacy Texas LLC dba Strive Pharmacy

7 citations3 action records4 explicit unknowns

Compounded with

Semaglutide

First-party medication page lists Semaglutide/Glycine/B12 injectable.

Tirzepatide

First-party medication page lists Tirzepatide/Glycine/B12 injectable.

Product evidence does not establish current availability.

Locations in the source record

Gilbert, Arizona
1430 S Main St Ste 105, Boerne, TX 78006
San Diego, California
Fenton, Missouri
Tampa, Florida

Services named by sources

503A patient-specific compounding
Sterile and nonsterile compounding
Weight-management formulations
Hormone therapy
Mental-health and skincare formulations

Regulatory compliance

503 pathway evidence

A pathway label describes which federal rules apply — it is not a quality claim.

Section 503A

Source-backed pathway evidence

Strive identifies its compounding operation as a licensed 503A pharmacy.

Section 503B

Not conclusively established

not found in current fda registry check

Telehealth providers

Programs with a verified source relationship

Only relationships named by an explicit bound source appear. A listing is not an availability, quality, or dispensing claim.

Enhance.MD

Compare providers using this pharmacy

Regulatory history

Actions stay dated and bounded.

FDA warning/closeout, Form 483, current 503B-registry, Texas board minutes, and Arizona action sources were checked. The Texas order's terms were not recovered.

U.S. Food and Drug Administration · 2022-08-29

Warning Letter

FDA later stated that Strive appeared to have adequately addressed the violations in warning letter 639220; FDA expressly preserved future enforcement authority.

closed_out_2026-05-13

U.S. Food and Drug Administration · 2023-09-08

Form FDA 483

FDA observed facility-design conditions allowing lower-quality air into classified areas, including a gap in an ISO 7 cleanroom.

issued

Texas State Board of Pharmacy · 2026-02

Agreed Board Order

The board minutes show the order and vote but the substantive terms were not recovered; they remain unverified.

Status not stated

What remains unverified

Founded year
Complete state-license footprint
Texas agreed-board-order terms
Current shipping eligibility by state

Patient reviews

Share your experience for moderation

No Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.

What this record verifies for you

6 evidence dimensions carry dated, source-backed verification.

Each line traces to a citation in the source list below — read the exact captured wording before relying on it.

dated source ledger: 7 first-party/regulator citations with URL, accessed date, and exact supporting quote.
legal entity provenance: Legal entity recorded as Strive Pharmacy Texas LLC dba Strive Pharmacy with status verified_fda_for_texas_facility.
regulatory action timeline: 3 dated regulatory/action record(s) with bounded summaries and regulator citations.
503 status provenance: 503A/503B fields preserve pathway, source status, and current-versus-historical limits from the bound research.
source bound glp relevance: GLP relevance status is verified_first_party, tied to the record citation ledger.
transparent unknowns: 4 unresolved field(s) are explicitly named and prevented from rendering as facts.

No superiority claim is made for review volume, ratings, or patient sentiment.

Sources and exact captured wording

first_party · accessed 2026-08-20
We're licensed in every state where our medications are dispensed. After sourcing, ingredients are brought into our licensed 503A pharmacy.
first_party · accessed 2026-08-20
Semaglutide/Glycine/B12 is an injectable medication that helps regulate blood sugar, reduce appetite, and lower inflammation.
first_party · accessed 2026-08-20
Tirzepatide/Glycine/B12 is an injectable medication that helps regulate blood sugar, reduce appetite, and lower inflammation.
fda · accessed 2026-08-20
OBSERVATION 1: The facility design was observed to allow the influx of lesser quality air into a classified area containing higher quality air.
fda · accessed 2026-08-20
FDA has completed an evaluation of your firm’s corrective actions in response to our warning letter #639220, issued on August 29, 2022. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
state_board · accessed 2026-08-20
Strive Pharmacy LLC | P | ABO | 2025-02040 | 8-0-2 | Martin, Yoakum
fda · accessed 2026-08-20
Updated as of 8/18/2026 ... This table lists the outsourcing facilities that have submitted registration information that has been determined to be complete by the data lock date for the latest weekly update of the table.

Questions readers ask

Is Strive Pharmacy legit?

GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 7 dated first-party or regulator citation(s), 3 regulatory/action record(s), and 4 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.